Clinical Trials Browser

OTHER × Lung Neoplasms × alectinib × Clear all

NCT03202940 2026-05-08

A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05987644 2026-04-08

DURABLE

Phase 1/2 Recruiting

Brain Neoplasms, Lung Neoplasms

NCT05525338 2024-05-13

ADAPT ALEC

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05081674 2023-10-11

BLISS

Phase 2 Completed

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04708639 2021-02-02

MonAlec

Lung Neoplasms, Disease Resistance